Bioworld Financial Watch articles from November 2006

Bioworld Financial Watch archives from November 2006

Merck's $1.1b Sirna buyout leaves IP questions open.
November 6, 2006... "Unquestionably, we're the leaders [in RNA interference]," Van Miles, senior vice president of business development for Alnylam Pharmaceuticals Inc., said about a year ago. Howard Robin, CEO of Sirna Therapeutics Inc., disagreed, choosing to...

10 biggest U.S. gainers for the week.(Company rankings)
November 6, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Sirna Therapeutics 94.92 Memory Pharma 65.61 Alliance Pharma 27.27 Biomimetic Thera 26.70 Targacept 21.63 Helix Biomedix 21.43 CytRx ...

10 biggest U.S. losers for the week.(Company rankings)
November 6, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Avanir -58.28 VaxGen -57.66 Cellegy Pharma -38.46 Neurocrine Biosci -35.77 Emisphere Techno -33.11 Valentis -32.35...

Public financing of biotechnology: October 2006.(Statistical data)
November 6, 2006... Public Financing Of Biotechnology: October 2006 I. COMMENCED TRADING IN OCTOBER Company Date Date Shares/ (Symbol)# Filed Comm. Units (M) Price INITIAL OFFERINGS Achillion ...

Other financing of public biotechnology companies: October 2006.(Statistical data)
November 6, 2006... Other Financings Of Public Biotechnology Companies: October 2006 TOTAL: $759.14 Number Of Amount Shares, Units Raised Company Type Of...

Venture capital and other investments in private biotechnology companies: October 2006.(Statistical table)
November 6, 2006... Venture Capital And Other Investments In Private Biotechnology Companies: October 2006 FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES:$529.68M Company Location Date Amt. (M) Achaogen Inc. South...

Milestone payments from corporate partners: October 2006.
November 6, 2006... Milestone Payments From Corporate Partners: October 2006 TOTAL: $22.5M Year to Date: $515.37M Company Partner Amt. Triggering (Symbol) (#) * (Country) (M) Event Can-Fite ...

Money raised by biotech in 2006: January-October.(Statistical data)
November 6, 2006... Money Raised By Biotech In 2006: January-October Type of financing Jan. Feb. March April Public offerings 542.2 486.8 922.3 574.3 Private biotechs 476.3 306.3 380.8 377.1...

BioWorld stock report for public biotechnology companies.(Statistical data)
November 6, 2006... BioWorld Stock Report For Public Biotechnology Companies Close Close Company Symbol 10/27 11/03 Aastrom Biosci ASTM 1.43 1.51 Acadia Pharma ACAD ...

Previous success indicators prove shaky; markets wary.(Conference news)
November 13, 2006... DUSSELDORF, Germany -- At the 12th annual BIO-Europe International Partnering Conference here, almost all the talk--on panels, in the hallways, at the receptions--seemed to focus on the heightened rate of mergers and acquisitions. Pharma...

10 biggest U.S. gainers for the week.(Brief article)(Statistical data)(Company rankings)
November 13, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Targeted Genetics 100.00 Tanox 5.99 Poniard Pharma 57.14 Osiris Therapeutics 5.65 Tanox 43.53...

10 biggest U.S. losers for the week.(pharmaceutical companies)(Brief article)(Statistical data)(Company rankings)
November 13, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Adolor -44.19 Adolor -6.16 Valera Pharma -21.97 New River Pharma -2.88 Palatin Technologies -21.15...

Collaborations between biotech and pharmaceutical companies: Sept. 21-Nov. 8, 2006 (#).
November 13, 2006... Collaborations Between Biotech And Pharmaceutical Companies: Sept. 21-Nov. 8, 2006 (#) Biotech Co. * Pharma Co. Type/Product Area (Country; (Country) Symbol) Aegerion Pfizer Inc. ...

Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies: Sept. 21-Nov. 8, 2006 (#).(Table)
November 13, 2006... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Sept. 21-Nov. 8, 2006 (#) Biotech Co. * Pharma Co. Product (Country; (Country) Symbol) Cleveland ...

Biotech--big pharma collaborations: modified and terminated agreements, Sept. 21-Nov. 8, 2006 (#).(Table)(Brief article)
November 13, 2006... Biotech--Big Pharma Collaborations: Modified And Terminated Agreements, Sept. 21-Nov. 8, 2006 (#) I. MODIFIED AGREEMENTS Biotech Co. * Pharma Co. Change from original (Country; (Country) agreement...

BioWorld stock report for public biotechnology companies.(Statistical table)
November 13, 2006... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 11/03 11/10 WK YTD (000) Aastrom Biosci ASTM 1.51...

Genentech's Tanox takeover turns investor eyes to Xolair.(Late-Stage HIV Drug Not Viable: Analyst)
November 20, 2006... When thinking about buyouts, most industry observers would hardly consider Genentech Inc. first. The premier biotech firm is too big, too successful to be a likely target itself, and snatching up smaller firms has not been Genentech's...

10 biggest U.S. gainers for the week.(Brief article)(Company rankings)
November 20, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Vanda Pharma 45.74 Embrex 4.70 Allos Therapeutics 40.47 Sepracor 4.70 Embrex 39.36 Vanda...

10 biggest U.S. losers for the week.(Brief article)(Company rankings)
November 20, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Tripos -63.47 Illumina -3.72 Favrille -27.82 Infinity Pharma -2.13 Northwest Biothera -25.00 Amylin...

Clinical trials update: October 2006.(List)
November 20, 2006... Clinical Trials Update: October 2006 Company * Product Description Indication (Country; Symbol) AUTOIMMUNE Array ARRY-438162 Small-molecule Inflammatory BioPharma ...

Non-U.S. clinical trials and regulatory actions: October 2006.(List)
November 20, 2006... Non-U.S. Clinical Trials And Regulatory Actions: October 2006 Company * Product Description Indication (Country; Symbol) AUTOIMMUNE Biogen Idec Tysabri Natalizumab; Multiple...

FDA submissions, approvals and other actions: October 2006.(List)
November 20, 2006... FDA Submissions, Approvals And Other Actions: October 2006 Company * Product Description Indication (Country; Symbol) AUTOIMMUNE Centocor Inc. Remicade Infliximab; Ulcerative...

BioWorld stock report for public biotechnology companies.(Statistical table)
November 20, 2006... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 11/10 11/17 Aastrom Biosci ASTM 1.46 1.47 Acadia Pharma ACAD ...

Registry could be key asset in Actelion's CoTherix buyout.(Complicated PAH War Goes On)
November 27, 2006... In early 2003, when Johnson & Johnson bought Scios Corp. for $2.4 billion in cash, the most talked-about drivers of the deal were Natrecor (nesiritide), Scios' approved drug for congestive heart failure; an arthritis drug in the works,...

Biotech Collaborations and other actions in agriculture and animals: Nov. 23, 2005-Nov. 21, 2006.
November 27, 2006... UNLIMITED access to Bio World Snapshots, a powerful data-tracking tool. FREE to all Bio World Today Online subscribers! Tap into this real-time database with key data and figures from the biotech industry. Data are updated continuously with...

BioWorld Stock Report for Public Biotechnology Companies.(Statistical table)
November 27, 2006... Close Close %Change Vol Company Symbol 11/17 11/22 WK YTD (000) Aastrom Biosci ASTM 1.47 1.4 -4.76 -33.65 4491 Acadia Pharma ACAD ...

Just released: BioWorld Biofuels Report 2007; Market realities, perspectives and challenges.(Brief article)
November 27, 2006... This new report from BioWorld Today offers insight into the history, statistics and forecasts of the Biofuels market, and provides a balanced view of the industry, addressing key issues and analyzing facts to-date. A detailed overview of the...